Transcription of （別添様式1） - mhlw.go.jp
1 ;II-95 1 1 IPF IPF , 50-200 / 100-150ng/ml) ;II-95 2 FVC FVC 2 6 6.
2 II-95 3 6 6 6 ;II-95 4 ;II-95 5 3 + N IPF + + 2 Peer-reviewed journal ;II-95 6 + / ATS/ERS A IPF , 2 , 2011.
3 IPF fibrotic NSIP Fibrotic NSIP fibrotic NSIP IPF fibrotic NSIP ;II-95 7 , 50-200 / 100-150ng/mL IPF fibrotic NSIP IPF 4 5 1 , 2 , 2011.
4 Ganesh Raghu, et al. An Official ATS/ERS/JRS/ALAT Statement: IdiopathicPulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management Am J Respir Crit Care Med 183. 788 824, 2011 51 49: 143, 2011. Miyazaki Y, Azuma A et al: Randomized, double-blind, multi-centered controlled trial of cyclosporine A vs. Cyclophosphamide with corticosteroid in patients with idiopathic pulmonary fibrosis ATS 2011. Abstract p286
